Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 1999

View Archived Issues

Sulfonylureas linked to increase in early mortality after angioplasty for acute MI

Antiallergic peptide compounds available for licensing from Yeda

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

Procyon receives Canadian patent for PSP94

Reanalysis of data attributes greater efficacy to Multikine

CuraGen and Roche reach drug discovery agreement

Cantab: 1998 year-end highlights

Small Molecule Therapeutics and Hybrigenics enter drug discovery collaboration

Venous leg ulcers unlikely to heal with compression therapy can be predicted at 4 weeks

U. of California reports new purine cyclin-dependent kinase inhibitors

Suntory synthesizes new inhibitors of PDE4 and TNF-alpha production

Aminoethylphenoxyacetic acids for urinary lithiasis in development at Kissei

New differentiation-inducing vitamin D compounds from Japanese lab

Lilly's new agents for lipid disorders act by increasing HDL cholesterol levels

Glaxo Wellcome seeks U.S. regulatory approval for combination asthma treatment

Hemosol product advances; company receives milestone payment from Fresenius

Boston Biomedica receives 510(k) clearance for Lyme IgM Western Blot test kit

Elastase inhibitor from Teijin looks promising in the treatment of respiratory disease

Suntory's neuroprotective compound SUN-N4057 is effective in rat models

Preclinical studies support BM-17.0744 as a potential treatment for metabolic syndrome

HMR-1883: not a classical antiarrhythmic agent

Studies show that ketolide compound ABT-773 is a promising new antimicrobial agent

Bristol-Myers Squibb drops antimigraine drug from the pipeline

In vitro data supporting antifungal efficacy of Nyotran presented at ECCMID

New antileukemia agents synthesized at Hughes Institute

More news from the ACS: DuPont synthesizes anti-HIV compounds derived from efavirenz

ACS highlights: Dainippon selects potent antitumor compound for development

NovoSeven approved in the U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...